YD Bio (NASDAQ:YDES) Shares Down 7.8% – Here’s What Happened

YD Bio Limited (NASDAQ:YDES) traded down 7.8% during mid-day trading on Wednesday . The stock traded as low as $3.65 and last traded at $3.92. 728,327 shares changed hands during mid-day trading, an increase of 257% from the average session volume of 203,905 shares. The stock had previously closed at $4.25.

YD Bio Trading Up 2.6%

The firm has a fifty day simple moving average of $2.98 and a 200-day simple moving average of $4.53.

YD Bio (NASDAQ:YDES) last posted its earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share for the quarter. The firm had revenue of $0.42 million during the quarter.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Cypress Capital Management LLC WY grew its position in YD Bio Limited (NASDAQ:YDES) by 9.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,690 shares of the biotechnology company’s stock after acquiring an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent reporting period.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.